Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

The stock's fall snapped a three-day winning streak.

Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, ...

Moderna stock reversed losses on its fourth-quarter report after CEO Stephane Bancel deflected concerns over RFK Jr. Is MRNA ...

Executives are trying to influence the policies beginning to take shape and mitigate negative effects of things like tariffs and regulation overhauls.

Every fall and winter, the United States sees an uptick in the number of people who fall ill to influenza and other seasonal diseases. This flu season typically stretches from October to ...

Shares of Novavax Inc. NVAX rallied 4.47% to $8.18 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.50% to ...